| Dr Seetha Devi Sureddi, MD | |
|
1400 Bryan Dr, Suite 300, Durant, OK 74702 | |
| (580) 924-1700 | |
| (580) 924-1736 |
| Full Name | Dr Seetha Devi Sureddi |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 55 Years |
| Location | 1400 Bryan Dr, Durant, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376581314 | NPI | - | NPPES |
| 100016390A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 11979 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Charlton Medical Center | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Phases Of Life Womens Health Care, Pa | 6901953157 | 2 |
News Archive
Politico: "Through the summer, congressional Republicans were able to stand back and let the health care debate play out around them — watching public support for the idea plummet amid bitter town halls and Democratic infighting." And even as the chances increase that "President Barack Obama will have a chance to sign a health reform bill, Republicans say they're content to stick by that strategy — believing they can define the Democratic plan as a bad mix of higher premiums, more taxes and cuts to Medicare. And that, they believe, is a winning formula for them in 2010."
David H. Adams, MD, Marie-Josée and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery at The Mount Sinai Medical Center, performed the first two implantations of the Carpentier-Edwards Physio II ring in the United States yesterday.
Nova Southeastern University and the dietary supplement company Immunotec announced today that they will conduct a new research study to determine the effects of a supplement to improve behaviors in children with Autism Spectrum Disorder.
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
EDP Biotech Corporation was awarded a $244,000 grant from the federal government under the Qualifying Therapeutic Discovery Project program as a result of the company's work in the development of their ColoMarker test, an early detection blood test for colon cancer.
› Verified 5 days ago
| Entity Name | Phases Of Life Womens Health Care, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033307368 PECOS PAC ID: 6901953157 Enrollment ID: O20090406000299 |
News Archive
Politico: "Through the summer, congressional Republicans were able to stand back and let the health care debate play out around them — watching public support for the idea plummet amid bitter town halls and Democratic infighting." And even as the chances increase that "President Barack Obama will have a chance to sign a health reform bill, Republicans say they're content to stick by that strategy — believing they can define the Democratic plan as a bad mix of higher premiums, more taxes and cuts to Medicare. And that, they believe, is a winning formula for them in 2010."
David H. Adams, MD, Marie-Josée and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery at The Mount Sinai Medical Center, performed the first two implantations of the Carpentier-Edwards Physio II ring in the United States yesterday.
Nova Southeastern University and the dietary supplement company Immunotec announced today that they will conduct a new research study to determine the effects of a supplement to improve behaviors in children with Autism Spectrum Disorder.
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
EDP Biotech Corporation was awarded a $244,000 grant from the federal government under the Qualifying Therapeutic Discovery Project program as a result of the company's work in the development of their ColoMarker test, an early detection blood test for colon cancer.
› Verified 5 days ago
| Entity Name | Elite Women's Wellness Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285414565 PECOS PAC ID: 7618311572 Enrollment ID: O20240219002462 |
News Archive
Politico: "Through the summer, congressional Republicans were able to stand back and let the health care debate play out around them — watching public support for the idea plummet amid bitter town halls and Democratic infighting." And even as the chances increase that "President Barack Obama will have a chance to sign a health reform bill, Republicans say they're content to stick by that strategy — believing they can define the Democratic plan as a bad mix of higher premiums, more taxes and cuts to Medicare. And that, they believe, is a winning formula for them in 2010."
David H. Adams, MD, Marie-Josée and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery at The Mount Sinai Medical Center, performed the first two implantations of the Carpentier-Edwards Physio II ring in the United States yesterday.
Nova Southeastern University and the dietary supplement company Immunotec announced today that they will conduct a new research study to determine the effects of a supplement to improve behaviors in children with Autism Spectrum Disorder.
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
EDP Biotech Corporation was awarded a $244,000 grant from the federal government under the Qualifying Therapeutic Discovery Project program as a result of the company's work in the development of their ColoMarker test, an early detection blood test for colon cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Seetha Devi Sureddi, MD 1400 Bryan Dr Ste 301, Durant, OK 74701-2158 Ph: (580) 924-1700 | Dr Seetha Devi Sureddi, MD 1400 Bryan Dr, Suite 300, Durant, OK 74702 Ph: (580) 924-1700 |
News Archive
Politico: "Through the summer, congressional Republicans were able to stand back and let the health care debate play out around them — watching public support for the idea plummet amid bitter town halls and Democratic infighting." And even as the chances increase that "President Barack Obama will have a chance to sign a health reform bill, Republicans say they're content to stick by that strategy — believing they can define the Democratic plan as a bad mix of higher premiums, more taxes and cuts to Medicare. And that, they believe, is a winning formula for them in 2010."
David H. Adams, MD, Marie-Josée and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery at The Mount Sinai Medical Center, performed the first two implantations of the Carpentier-Edwards Physio II ring in the United States yesterday.
Nova Southeastern University and the dietary supplement company Immunotec announced today that they will conduct a new research study to determine the effects of a supplement to improve behaviors in children with Autism Spectrum Disorder.
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
EDP Biotech Corporation was awarded a $244,000 grant from the federal government under the Qualifying Therapeutic Discovery Project program as a result of the company's work in the development of their ColoMarker test, an early detection blood test for colon cancer.
› Verified 5 days ago
Allison A Taylor, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 Bryan Dr Ste 301, Durant, OK 74701 Phone: 809-209-0635 Fax: 316-634-0050 | |
Dr. Autumn Lynn Hensley, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 Bryan Dr Ste 208, Durant, OK 74701 Phone: 580-920-9063 Fax: 833-450-0357 | |
Braulio Manny Cuesta, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1400 Bryan Dr, Durant, OK 74701 Phone: 580-920-0105 Fax: 580-920-0893 |